CLINICAL

Health Care a Central Issue in President Trump’s Speech to CongressIn his address to Congress, Trump hinted at what could be in the future for healthcare reform.
Rite Aid, Albertsons Expand Naloxone AccessRite Aid and Albertsons expand naloxone Access, hoping to curb the opioid epidemic.
How Did You Participate in Rare Disease Day 2017?Rare Disease Day is held every year on the last day of February to help spread awareness about rare diseases and the people they impact.
Small Doses: The news you need to be the bestA look at four important drug studies and stories that you need to know about.
New CDC Study Finds Shocking Rates of Overdose DeathsA new CDC study shows that drug overdose deaths have been on the rise and are likely to keep rising.
Beyond Beta-Blockers: Ivabradine for CHFReview of new drug Ivabradine (Corlanor) approved by the FDA for the management of heart failure.
FDA approves lixisenatide for type 2 diabetesNew drug review
Pharmacies Look to Add Value By Offering Tuberculosis TestingAs community pharmacies strive to play a greater role in population health management, could TB testing be an important item on the service menu?
A Class of Their Own: The Unique Challenges of Type I DiabetesWhile many aspects of diabetes care are universal, patients with type I diabetes (T1D) often face a unique set of obstacles and challenges.
Ixazomib for multiple myelomaFDA approved ixazomib (Ninlaro, Takeda) in combination with lenalidomide and dexamethasone

Poll